Table 1.

Clinical characteristics of cohort at study entry, Hb <11 versus ≥11 g/dl, N = 677a

Baseline Clinical CharacteristicsHb < 11 g/dl (n = 298; 44%; n [%] or Mean [SD])Hb ≥ 11 g/dl (n = 379; 56%; n [%] or Mean [SD])
Age (yr)15.9 (±1.8)16 (±1.6)
White race140 (47)190 (50)
Male gender144 (48)210 (55)
Congenital/urologic cause of ESRD123 (41)154 (41)
HD initiation ≥ 180 db125 (42)245 (65)
HD access type: catheterb177 (59)140 (37)
Medicare/Medicaid coverage152 (51)188 (50)
Serum albumin ≥ 3.5/3.2 g/dlb,c212 (71)339 (89)
Mean serum ferritin (ng/ml)261.9 (±359)259 (±272)
Presence of baseline HTNb112 (38)117 (31)
eGFR by Schwartz (ml/min per 1.73 m2)9.2 (±6.9)9.6 (±6.2)
Iron use (yes)216 (72)295 (78)
Mean epoetin dosage (units/kg per wk)b370.6 (±265.4)254.6 (±203)
Patients who received transplant during study87 (29)129 (34)
  • a BCG/BCP, Bromcresol green/Bromcresol purple; eGFR, estimated GFR; Hb, hemoglobin; HD, hemodialysis; HTN, hypertension.

  • b P ≤ 0.05 (χ2 or ANOVA).

  • c BCG/BCP.